Birth Outcomes of Anticancer Drug Prescriptions during Pregnancy: A Case Series from a Japanese Claims Database
We aimed to evaluate the adverse birth outcomes of anticancer drug prescription during pregnancy using a Japanese claims database from 2005 to 2019. We applied validated claims-based algorithms to identify pregnant women with birth outcomes, and evaluated drug prescription during pregnancy. The caus...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-01-01
|
| Series: | Pharmacoepidemiology |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2813-0618/2/1/2 |
| _version_ | 1797609514651877376 |
|---|---|
| author | Kentaro Tajima Tomofumi Ishikawa Masami Tsuchiya Masafumi Kikuchi Taku Obara Nariyasu Mano |
| author_facet | Kentaro Tajima Tomofumi Ishikawa Masami Tsuchiya Masafumi Kikuchi Taku Obara Nariyasu Mano |
| author_sort | Kentaro Tajima |
| collection | DOAJ |
| description | We aimed to evaluate the adverse birth outcomes of anticancer drug prescription during pregnancy using a Japanese claims database from 2005 to 2019. We applied validated claims-based algorithms to identify pregnant women with birth outcomes, and evaluated drug prescription during pregnancy. The causal relationship between anticancer drugs and adverse birth outcomes was evaluated using the Council for International Organizations of Medical Sciences Working Group VI criteria. Thirteen women with anticancer drugs prescription during pregnancy were identified (mean age: 34.6 years). Atrial/ventricular septal defect was observed in one infant after exposure to cyclophosphamide and doxorubicin for breast cancer in the second and third trimesters. One woman on several anticancer drugs (cyclophosphamide, cytarabine, daunorubicin, l-asparaginase, methotrexate, nelarabine, and vincristine) for acute lymphoblastic leukemia, one on imatinib for chronic myeloid leukemia, and one on cisplatin and fluorouracil for cervical cancer had miscarriages after exposure in the first trimester. A relationship between those anticancer drugs and miscarriage could not be ruled out, while no relationship was identified regarding the atrial/ventricular septal defect considering the period of exposure and organogenesis. Our results suggest increased risk of miscarriage with the use of several anticancer drugs such as methotrexate, imatinib, cisplatin, and fluorouracil in the first trimester. |
| first_indexed | 2024-03-11T06:01:30Z |
| format | Article |
| id | doaj.art-b08fdb97dc1544cfb2c746eae95f80cf |
| institution | Directory Open Access Journal |
| issn | 2813-0618 |
| language | English |
| last_indexed | 2024-03-11T06:01:30Z |
| publishDate | 2023-01-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Pharmacoepidemiology |
| spelling | doaj.art-b08fdb97dc1544cfb2c746eae95f80cf2023-11-17T13:17:48ZengMDPI AGPharmacoepidemiology2813-06182023-01-0121132510.3390/pharma2010002Birth Outcomes of Anticancer Drug Prescriptions during Pregnancy: A Case Series from a Japanese Claims DatabaseKentaro Tajima0Tomofumi Ishikawa1Masami Tsuchiya2Masafumi Kikuchi3Taku Obara4Nariyasu Mano5Laboratory of Biomolecule and Pathophysiological Chemistry, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai 980-8574, JapanLaboratory of Biomolecule and Pathophysiological Chemistry, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai 980-8574, JapanLaboratory of Biomolecule and Pathophysiological Chemistry, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai 980-8574, JapanPharmacy Education and Research Center, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai 980-8578, JapanDepartment of Pharmaceutical Sciences, Tohoku University Hospital, Sendai 980-8574, JapanLaboratory of Biomolecule and Pathophysiological Chemistry, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai 980-8574, JapanWe aimed to evaluate the adverse birth outcomes of anticancer drug prescription during pregnancy using a Japanese claims database from 2005 to 2019. We applied validated claims-based algorithms to identify pregnant women with birth outcomes, and evaluated drug prescription during pregnancy. The causal relationship between anticancer drugs and adverse birth outcomes was evaluated using the Council for International Organizations of Medical Sciences Working Group VI criteria. Thirteen women with anticancer drugs prescription during pregnancy were identified (mean age: 34.6 years). Atrial/ventricular septal defect was observed in one infant after exposure to cyclophosphamide and doxorubicin for breast cancer in the second and third trimesters. One woman on several anticancer drugs (cyclophosphamide, cytarabine, daunorubicin, l-asparaginase, methotrexate, nelarabine, and vincristine) for acute lymphoblastic leukemia, one on imatinib for chronic myeloid leukemia, and one on cisplatin and fluorouracil for cervical cancer had miscarriages after exposure in the first trimester. A relationship between those anticancer drugs and miscarriage could not be ruled out, while no relationship was identified regarding the atrial/ventricular septal defect considering the period of exposure and organogenesis. Our results suggest increased risk of miscarriage with the use of several anticancer drugs such as methotrexate, imatinib, cisplatin, and fluorouracil in the first trimester.https://www.mdpi.com/2813-0618/2/1/2cancerclaims databaseJapanlive birthmiscarriage |
| spellingShingle | Kentaro Tajima Tomofumi Ishikawa Masami Tsuchiya Masafumi Kikuchi Taku Obara Nariyasu Mano Birth Outcomes of Anticancer Drug Prescriptions during Pregnancy: A Case Series from a Japanese Claims Database Pharmacoepidemiology cancer claims database Japan live birth miscarriage |
| title | Birth Outcomes of Anticancer Drug Prescriptions during Pregnancy: A Case Series from a Japanese Claims Database |
| title_full | Birth Outcomes of Anticancer Drug Prescriptions during Pregnancy: A Case Series from a Japanese Claims Database |
| title_fullStr | Birth Outcomes of Anticancer Drug Prescriptions during Pregnancy: A Case Series from a Japanese Claims Database |
| title_full_unstemmed | Birth Outcomes of Anticancer Drug Prescriptions during Pregnancy: A Case Series from a Japanese Claims Database |
| title_short | Birth Outcomes of Anticancer Drug Prescriptions during Pregnancy: A Case Series from a Japanese Claims Database |
| title_sort | birth outcomes of anticancer drug prescriptions during pregnancy a case series from a japanese claims database |
| topic | cancer claims database Japan live birth miscarriage |
| url | https://www.mdpi.com/2813-0618/2/1/2 |
| work_keys_str_mv | AT kentarotajima birthoutcomesofanticancerdrugprescriptionsduringpregnancyacaseseriesfromajapaneseclaimsdatabase AT tomofumiishikawa birthoutcomesofanticancerdrugprescriptionsduringpregnancyacaseseriesfromajapaneseclaimsdatabase AT masamitsuchiya birthoutcomesofanticancerdrugprescriptionsduringpregnancyacaseseriesfromajapaneseclaimsdatabase AT masafumikikuchi birthoutcomesofanticancerdrugprescriptionsduringpregnancyacaseseriesfromajapaneseclaimsdatabase AT takuobara birthoutcomesofanticancerdrugprescriptionsduringpregnancyacaseseriesfromajapaneseclaimsdatabase AT nariyasumano birthoutcomesofanticancerdrugprescriptionsduringpregnancyacaseseriesfromajapaneseclaimsdatabase |